237
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Acetylcholinesterase measurement in various brain regions and muscles of juvenile, adolescent, and adult rats

ORCID Icon, , , , , & show all
Pages 666-676 | Received 20 Jan 2017, Accepted 28 Jun 2017, Published online: 18 Jul 2017

References

  • Abramson SN, Radic Z, Manker D, Faulkner DJ, Taylor P. 1989. Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action. Mol Pharmacol. 36:349–354.
  • Atterberry TT, Burnett WT, Chambers JE. 1997. Age-related differences in parathion and chlorpyrifos toxicity in male rats: target and non-target esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol Appl Pharmacol. 147:411–418.
  • Bajgar J, Hajek P, Karasova J, Slizova D, Krs O, Kuca K, Jun D, Fusek J, Capek L. 2007. Inhibition of acetylcholinesterase in different structures of the rat brain following soman intoxication pretreated with Huperzine A. IJMS. 8:1165–1176.
  • Beyrouty P. 2002. A study on the effects of orally administered methyl parathion on cholinesterase levels in adult, juvenile, and neonatal rats. ClinTrials BioResearch Ltd., Senneville, Quebec. Lab Project Number: 97558, February 26, 2002, MRID 45656501, Unpublished.
  • Calabrese E, Badea A, Watson C, Johnson GA. 2013. A quantitative magnetic resonance histology atlas of postnatal rat brain development with regional estimates of growth and variability. Neuroimage. 71:196–206.
  • Camarini R, Benedito MAC. 1997. Chronic imipramine treatment-induced changes in acetylcholinesterase (EC 3.1.1.7) activity in discrete rat brain regions. Braz J Med Biol Res. 30:955–960.
  • Christenson WR, Van Goethem DL, Schroeder RS, Wahle BS, Dass PD, Sangha GK, Thyssen JH. 1994. Interlaboratory cholinesterase determinations and the effect on the results of statistical evaluation of cholinesterase inhibition. Toxicol Lett. 71:139–150.
  • Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vesna M, Vasic VM. 2013. Acetylcholinesterase Inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 11:315–335.
  • Ellman GL, Courtney DK, Andres V, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
  • European Medicines Agency (EMEA). 2011. Guideline on bioanalytical method validation, EMEA/CHMP/EWP/19221/2009, London, UK.
  • Fulcher SM. 2001. Malathion – effects on cholinesterase in the CD rat (adult and juvenile) by oral gavage administration, Huntingdon Life Sciences, Ltd., Cambridgeshire, England. Laboratory study no. CHV067/012452, November 30, 2001, MRID 45566201, Unpublished.
  • Glowinski J, Iversen LL. 1966. Regional studies of catecholamines in the rat brain – I. The disposition of [3H]Norepinephrine, [3H]Dopamine and [3H]Dopa in various regions of the brain. J Neurochem. 13:655–669.
  • Goldberg JA, Reynolds JNJ. 2011. Review: sponaneous firing and evoked pauses in the tonically active cholinergic interneurons of the striatum. Neuroscience. 198:27–43.
  • Howerton TC, Murphy MR, Miller SA, Hartgraves SL. 1991. Differential sensitivity of CNS regions to acetylcholinesterase inhibition following chronic low-dose soman treatment in the rat. Psychopharmacology (Berl). 105:400–406.
  • Hunter DL, Padilla S. 1999. Influence of storage conditions on the stability of cholinesterase activity in plasma and brain tissue taken from carbamate or organophosphorus pesticide-treated rats. Toxicol Methods. 9:189–199.
  • Iwahara S-I, Abe Y, Okazaki T. 1996. Identification of five embryonic hemoglobins of rat and ontogeny of their constituent globins during fetal development. J Biochem. 119:360–366.
  • Jelkmann W, Bauer C. 1980. 2,3-DPG levels in relation to red cell enzyme activities in rat fetuses and hypoxic newborns. Pflugers Arch. 389:61–68.
  • Karanth S, Pope C. 2000. Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol Sci. 58:282–289.
  • Lassiter TL, Marshall RS, Jackson LC, Hunter DL, Vu JT, Padilla S. 2003. Automated measurement of acetylcholinesterase activity in rat peripheral tissues. Toxicology. 186:241–253.
  • Lassiter TL, Padilla S, Mortensen SR, Chanda SM, Moser VC, Barone S. 1998. Gestational exposure to chlorpyrifos: apparent protection of the fetus. Toxicol Appl Pharmacol. 152:56–65.
  • Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. 1991. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci. 11:3218–3226.
  • Liu J, Olivier K, Pope CN. 1999. Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats. Toxicol Appl Pharmacol. 158:186–196.
  • Mao C, Lv J, Li H, Chen Y, Wu J, Xu Z. 2007. Development of fetal nicotine and muscarinic receptors in utero. Braz J Med Biol Res. 40:735–741.
  • Mattsson JL, Maurissen JP, Nolan RJ, Brzak KA. 2000. Lack of differential sensitivity to cholinesterase inhibition in fetuses and neonates compared to dams treated perinatally with chlorpyrifos. Toxicol Sci. 53:438–446.
  • Meyers D. 2001. Dimethoate effects on cholinesterase in the CD rat (adult and juvenile) by oral gavage administration, Huntingdon Life Sciences, Ltd., Suffolk, England, Lab Project Number: CHV/070: 012226, MRID 45529702, Unpublished.
  • Mortensen SR, Hooper MJ, Padilla S. 1998. Rat brain acetylcholinesterase activity: developmental profile and maturational sensitivity to carbamate and organophosphorus inhibitors. Toxicology. 125:13–19.
  • Moser VC, Chanda SM, Mortensen SR, Padilla S. 1998. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci. 46:211–222.
  • OECD TG 443. 2011. Guideline for the Testing of Chemicals: Extended one-Generation Reproductive Toxicity Study, OECD Publishing, Paris, DOI: 10.1787/9789264122550-en
  • Padilla S, Buzzard J, Moser VC. 2000. Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos. Neurotoxicology. 21:49–56.
  • Pimlott SL, Piggott M, Owens J, Greally E, Court JA, Jaros E, Perry RH, Perry EK, Wyper D. 2004. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology. 29:108–116.
  • Pope C. 2001. Age and Interactive Toxicity of Organophosphorus Insecticides, U.S. Environmental Protection Agency. NCERQA Grant Project Number R 825811, February 28, 2002.
  • Ruehl-Fehlert C, Kittel B, Morawietz G, Deslex P, Keenan C, Mahrt CR, Nolte T, Robinson M, Stuart BP, Deschl U. 2003. Revised guides for organ sampling and trimming in rats and mice-part 1. Exp Toxicol Pathol. 55:91–106.
  • Rao DB, Little PB, Sills RC. 2014. Subsite awareness in neuropathology evaluation of National Toxicology Program (NTP) studies: a review of select neuroanatomical structures with their functional significance in rodents. Toxicol Pathol. 42:487–509.
  • Shih T-M, Skovira JW, O’Donnell JC, McDonough JH. 2009. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Toxicol Mech Methods. 19:386–400.
  • Shih T-M, Kan RK, McDonough JH. 2005. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact. 157–158:293–303.
  • Stiles J, Jernigan TL. 2010. The basics of brain development. Neuropsychol Rev. 20:327–348.
  • [US EPA] US Environmental Protection Agency, Docket number OPP-00432; FR-5364-5. 1996. Standard operating procedure for measuring cholinesterases in laboratory rats and dog exposed to non-reversible cholinesterase inhibitors. Federal Register, Vol. 61.
  • [US EPA] US Environmental Protection Agency. 2000b. Office of Pesticide Programs, Science Policy on the Use of Data on Cholinesterase Inhibition for Risk Assessments of Organophosphorous and Carbamate Pesticides, Washington DC.
  • [US EPA] US Environmental Protection Agency. 2000a. Responses to Public Comments on the Office of Pesticide Programs Science Policy on the Use of Data on Cholinesterase Inhibition for Risk Assessments of Organophosphorous and Carbamate Pesticides, Washington DC.
  • Wang BS, Wang H, Wie ZH, Song YY, Zhang L, Chen HZ. 2009. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. J Neural Transm (Vienna). 116:457–465.
  • Willis S, Hunter DL, Dass PD, Padilla S. 1996. Validation of the use of 6,6‘-dithiodinicotinic acid as chromogen in the Ellman method for cholinesterase determinations. Vet Hum Toxicol. 38:249–253.
  • Zheng Q, Olivier K, Won YK, Pope CN. 2000. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. Toxicol Sci. 55:124–132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.